Demerol on demand

PreclinicalSmall molecule

SSeoul National University Hospital

Demerol on demand is one of 7 small molecule programs targeting Nephrectomy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

NephrectomyCompleted

NephrectomyPreclinical

Completed

Competition

Competitive Landscape

6 competitors in Nephrectomy

#DrugCompanyPhaseTrials

Oxycontin

PProtega

Phase 2

2 2

Advil

KKenvue Brands

Phase 2

1 3

Dilaudid

RRhodes Pharmaceuticals, L.P.

Phase 2

1 4

Toradol

JJavelin Pharmaceuticals

Phase 2

1 5

Tylenol

KKenvue Brands

Phase 2

1 6

Esmeron

FFresenius Kabi USA, LLC

Preclinical

1 7

Demerol on demand

SSeoul National University Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Nephrectomy1 trial

The Intrathecal Morphine for Nephrectomy

Completed·SSeoul National University Hospital·N/A·NCT01997788·46 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Demerol on demand. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Demerol on demand compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Demerol on demand. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Seoul National University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSeoul National University Hospital

Demerol on demand

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Nephrectomy1 trial

References

Drug Info

Quick Facts

Related News